In vitro diagnostic substances, reagents, test kits and sets

Ended Awarded Feb 24, 2016 Last action Dec 6, 2022

Contract number: HHSN261201600012I
Awardee: Biopartners, Inc. UEI LKRBK3CCNNN9
Awarding agency: National Cancer Institute National Institutes of Health, Department of Health and Human Services
Task orders: 3 $673,270 obligated

Award facts

Opportunity: N02CO5441602 Solicitation number

Full and Open Competition Tissue Purchase Order Acquisitions for NCI's Clinical Proteomic Tumor Analysis Consortium (CPTAC) Award Notice · Posted Jul 30, 2015
Combined order value: $673,270 Current and potential, with all options
Last date to order 100% complete: Feb 23, 2021
IDV ceiling 10% used: $6,500,000.00
Award type: Multiple award
Who can order: Only the awarding agency
NAICS code: 325413 In-Vitro Diagnostic Substance Manufacturing
PSC: 6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside: No set-aside
Competition: Competed under SAP · 7 offers Simplified Acquisition
Pricing: Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

Task order	Ordering agency	Obligated	Awarded
Biopartners, INC.:1270141 [18-066447] 75N91018F00003	National Cancer Institute (NIH)	$28,560	Sep 17, 2018
TSS cptac digital medical images of cptac biospecimens HHSN26100002	National Cancer Institute (NIH)	$12,240	Sep 18, 2017
Biopartners, INC.:1270141 [16-021912] HHSN26100001	National Cancer Institute (NIH)	$632,470	Feb 24, 2016

Action	Obligated	Date
Supplemental Agreement for work within scope P00003	$0	Dec 6, 2022
Other Administrative Action 2 · Tissue source site (TSS) for clinical proteomics tumor analysis consortium (CPTAC)the purpose of this modification is to update two far clauses. See page 2…	$0	Sep 8, 2017
Other Administrative Action 1	$0	Feb 22, 2017
Original award	$0	Feb 24, 2016

HHSN261201600012I was awarded to Biopartners, Inc. by National Cancer Institute (National Institutes of Health) on February 24, 2016.

Orders under HHSN261201600012I have obligated $673,270. HHSN261201600012I's own ceiling is $6,500,000.

3 orders have been placed under HHSN261201600012I, the latest on September 17, 2018.

HHSN261201600012I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Yes. HHSN261201600012I is part of Tissue Source Site for Tumor Analysis.

The extent of competition for HHSN261201600012I was competed under sap. The government received 7 offers.

On GovTribe

Try for free Login